|
⚲
|
| Keyboard |
| Albert Sokol | |
|---|---|
| Firm | |
| Address | c/o Launchlabs 430 E 29th St, 14th Floor New York, NY 10016 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| ENB Therapeutics Inc | 021-493707 | Executive Officer | 0.2 M of 1.0 M |
||
| ENB Therapeutics Inc | 021-385913 | Executive Officer | 1.3 M of 2.6 M |
||
| ENB Therapeutics Inc | 021-321893 | Executive Officer | 8.1 M of 9.1 M |
||
| Isubscribed Inc | 021-319987 | Executive Officer | 0.0 M of 0.0 M |
||
| Isubscribed Inc | 021-313346 | Executive Officer | 12.1 M of 12.1 M |
||
| Euthymics Bioscience Inc | 021-287854 | Executive Officer | 0.3 M of 0.5 M |
||
| Neurovance Inc | 021-277876 | Executive Officer | 0.6 M of 0.6 M |
||
| Neurovance Inc | 021-258396 | Executive Officer | 7.5 M of 16.0 M |
||
| Neurovance Inc | 021-185561 | Executive Officer | 26.5 M of 26.5 M |
||